These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1233078)

  • 1. Horizontal studies of cell mediated immune reactions to autologous tumour antigens in patients with operable mammary carcinoma.
    Jones BM; Turnbull AR
    Br J Cancer; 1975 Sep; 32(3):339-44. PubMed ID: 1233078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
    Cochran AJ; Spilg WG; Mackie RM; Thomas CE
    Br Med J; 1972 Oct; 4(5832):67-70. PubMed ID: 5077468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of cellular immune response to cancer of the breast.
    Herberman RB
    Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular hypersensitivity to autologous tumor extract in patients with breast carcinoma.
    Akiyoshi T; Nakamura Y; Kawaguchi M; Tsuji H
    Jpn J Surg; 1978 Sep; 8(3):236-41. PubMed ID: 723017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immune responses of breast cancer patients to autologous tumor-associated antigens.
    Dean JH; McCoy JL; Cannon GB; Leonard CM; Perlin E; Kreutner A; Oldham RK; Herberman RB
    J Natl Cancer Inst; 1977 Mar; 58(3):549-55. PubMed ID: 138751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of serum-armed xenogeneic macrophages to breast cancer antigens.
    Harris LF; Miller LL; Hickok DF
    Cancer Res; 1982 Dec; 42(12):4985-90. PubMed ID: 7139603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunity in mammary cancer patients as measured by the leukocyte migration test (LMT). A follow-up study.
    Rieche K; Arndt A; Pasternak G
    Int J Cancer; 1976 Feb; 17(2):212-8. PubMed ID: 1248905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-directed leucocyte migration inhibition in operable breast cancer: additional clinical correlations.
    Jones BM; Connolly CE; Isaacson P; Turner DT; Turnbull AR
    Br J Cancer; 1976 Jul; 34(1):94-6. PubMed ID: 952719
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
    McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
    J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune reaction to human breast cancer: a comparison of skin and leucocyte migration tests.
    Roberts MM; Bathgate EM
    Br J Surg; 1975 Oct; 62(10):820-2. PubMed ID: 1191943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular responses to autologous breast cancer tissue. Correlation with stage and lymphoreticuloendothelial reactive.
    Black MM; Leis HP
    Cancer; 1971 Aug; 28(2):263-73. PubMed ID: 4935773
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro cellular immunity in mammary carcinoma.
    Jones BM; Turnbull AR
    Br J Cancer; 1974 Apr; 29(4):337-9. PubMed ID: 4852381
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of leucocyte migration by potassium chloride extracts of human tumor cells in ascites and from tissues.
    Imai K; Hosokawa Y; Abe H; Yachi A; Wada T
    Gan; 1977 Oct; 68(5):581-7. PubMed ID: 73489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-operative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
    Cochran AJ; Thomas CE; McKie RM; Spilg WG
    J Pathol; 1972 Jul; 107(3):Pv. PubMed ID: 5084947
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
    Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
    Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of leucocyte migration inhibition by breast tumour cell fractions.
    Jones BM
    Br J Cancer; 1976 Jul; 34(1):14-9. PubMed ID: 952712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.
    O'Connor R; MacFarlane JK; Murray D; Thomson DM
    Br J Cancer; 1978 Dec; 38(6):674-84. PubMed ID: 369586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations.
    Black MM; Zachrau RE; Shore B; Dion AS; Leis HP
    Cancer Res; 1978 Jul; 38(7):2068-76. PubMed ID: 207421
    [No Abstract]   [Full Text] [Related]  

  • 19. Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNA.
    Kern DH; Fritze D; Schick PM; Chow N; Pilch YH
    J Natl Cancer Inst; 1976 Jul; 57(1):105-9. PubMed ID: 1003493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pre- and postoperative reactivity of breast cancer patients to tumor associated antigens and HEP in the macrophage electrophoresis mobility (MEM) test].
    Ladusch M; Schäffner H; Ullmann L; Littmann M; Reimann S; Gindl P; Ambrosius H
    Arch Geschwulstforsch; 1982; 52(6):469-78. PubMed ID: 6186223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.